In Alzheimer’s disease, Avarol derivatives (such as thiosalycil-prenyl-hydroquinones) act as competitive acetylcholinesterase (AChE) inhibitors and show good neuroprotection [38,39]. The gene discussed is ACHE; the disease is Alzheimer disease.